0001123292-19-000911.txt : 20190626
0001123292-19-000911.hdr.sgml : 20190626
20190626161833
ACCESSION NUMBER: 0001123292-19-000911
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190624
FILED AS OF DATE: 20190626
DATE AS OF CHANGE: 20190626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Collier William H.
CENTRAL INDEX KEY: 0001780495
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 19921819
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORPORATION
STREET 2: 701 VETERANS CIRCLE
CITY: WARMINSTER
STATE: PA
ZIP: 18974
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-06-24
0001447028
Arbutus Biopharma Corp
ABUS
0001780495
Collier William H.
C/O ARBUTUS BIOPHARMA CORPORATION
701 VETERANS CIRCLE
WARMINSTER
PA
18974
1
1
0
0
President and CEO
Employee Stock Option (Right to Buy)
2.18
2019-06-24
4
A
0
1112000
0
A
2029-06-24
Common Shares
1112000
1112000
D
The stock option will vest and become exercisable as to 25% of the common shares on June 24, 2020 and as to an additional 1/48th of the total original number of common shares subject to Mr. Collier's stock option on the corresponding day of each month over the three year period thereafter, subject to Mr. Collier's continued employment with Arbutus Biopharma Corporation through the applicable vesting dates.
/s/ David C. Hastings, as attorney-in-fact for William H. Collier
2019-06-26